Corcept Therapeutics | CORT - 现金及等价物



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 12.65B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


现金及等价物 更改 日
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Alaunos Therapeutics USD 354K 1.03M 2026-03
ANI Pharmaceuticals USD 360.21M 49.04M 2026-06
Ardelyx USD 31.21M 36.79M 2026-03
Aurora Cannabis CAD 64.69M 8.33M 2026-03
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Canopy Growth CAD 364.68M 6.64M 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Eli Lilly USD 8.95B 3.67B 2026-06
J&J USD 20.42B 1.27B 2026-06
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Merck USD 6.85B 1.52B 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Novartis USD 7.62B 739M 2026-06
Novartis USD 6.88B 2.68B 2026-03
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 205.88M 61.57M 2026-06
Pfizer USD 976M 727M 2026-06
Supernus Pharmaceuticals USD 179.95M 4.92M 2026-06
TG Therapeutics USD 612.25M 170.04M 2026-06